Back to Search Start Over

Impact of PIK3CA mutations and P95HER2 expression on the outcome of HER2-positive metastatic breast cancer patients treated with a trastuzumab based therapy

Details

Database :
OpenAIRE
Journal :
Università di Pisa-IRIS
Accession number :
edsair.dedup.wf.001..e0e15eaa2bd6f6a52ff856d19f23541b